- HBV Mutations During Antiviral Therapy in Patients with Chronic Hepatits B
-
Hwang SG
- KMID: 1119357
- Korean J Hepatol.
- 2005 Dec;11(4):311-319.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
-
Cho EJ, Lee JH, Yoon JH
- KMID: 2412034
- Gut Liver.
- 2016 Jul;10(4):497-498.
- doi: 10.5009/gnl15307
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Epidemiology of Hepatitis B Virus
-
Kao JH
- KMID: 1022164
- Korean J Intern Med.
- 2011 Sep;26(3):255-261.
- doi: 10.3904/kjim.2011.26.3.255
Although safe and effective vaccines for hepatitis B virus (HBV) have been available for nearly three decades, this virus kills at least 600,000 people annually worldwide and remains the leading... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization
-
Sung PS, Bae SH, Jang JW, Song DS, Kim HY, Yoo SH, Park CH, Kwon JH, Song MJ, You CR, Choi JY, Yoon SK
- KMID: 1792608
- Korean J Hepatol.
- 2011 Dec;17(4):299-306.
- doi: 10.3350/kjhep.2011.17.4.299
BACKGROUND/AIMS: Enhanced replication of hepatitis C virus (HCV) is well described in the setting of moderate to severe immunosuppression. The aims of this retrospective study were to determine the incidence... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus
-
Lee HJ, Choi JW, Kim TN, Eun JR
- KMID: 1381468
- Korean J Hepatol.
- 2008 Sep;14(3):381-386.
- doi: 10.3350/kjhep.2008.14.3.381
Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administered at a high dosage. This is the first report of severe hypophosphatemic... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcome in Cases of Viral Breakthrough During Lamivudine Therapy in Chronic Hepatitis B Patients
-
Ahn SH, Chang YJ, Oh SN, Choi DW, Baek SJ, Jeong WS, Choi CW, Kim KO, Yim HJ, Jo NY, Bak JJ, Kim JS, Bak YT, Lee MS, Yeon JE, Byun KS, Lee CH
- KMID: 863114
- Korean J Hepatol.
- 2002 Dec;8(4):389-396.
BACKGROUND/AIMS: Long-term lamivudine therapy can induce the emergence of lamivudine resistant hepatitis B virus (HBV) mutants. Clinically emergence of the mutant is expressed by the reappearance of disappeared HBV... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B
-
Moon YM, Hwang SG, Kim BS, Rim KS, Cho M, Kim DJ, Han JY, Kim YS, Choi HS, Ahn SH
- KMID: 1776826
- Korean J Hepatol.
- 2007 Dec;13(4):503-512.
- doi: 10.3350/kjhep.2007.13.4.503
BACKGROUND AND AIMS: Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine is more potent than lamivudine for... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B
-
Kim IH, Kim SH, Kim HC, Shin KD, Kim SW, Lee SO, Lee ST, Kim DG
- KMID: 760736
- Korean J Hepatol.
- 2007 Sep;13(3):349-362.
- doi: 10.3350/kjhep.2007.13.3.349
BACKGROUND/AIMS: Adefovir dipivoxil (ADV) resistance in patients with lamivudine-resistant chronic hepatitis B is not well understood. This study examined the initial virologic response (IVR) to ADV, the rate of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant
-
Kim JK, Hwang SG, Park H, Choi HY, Cho HJ, Ko KH, Hong SP, Park PW, Kim NK, Rim KS
- KMID: 760605
- Korean J Hepatol.
- 2005 Sep;11(3):227-242.
BACKGROUND/AIMS: The therapeutic strategies of applying adefovir for treating lamivudine resistant HBV mutants are controversial. Thus, we observed the clinical outcomes after discontinuation of lamivudine to establish the timing... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
-
Kim HJ, Park SK, Yang HJ, Jung YS, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Choi KY
- KMID: 2373135
- Clin Mol Hepatol.
- 2016 Sep;22(3):350-358.
- doi: 10.3350/cmh.2016.0019
BACKGROUND/AIMS: To analyze the effects of preexisting lamivudine (LAM) resistance and applying antiviral treatment (adefovir [ADV] add-on LAM combination treatment) on long-term treatment outcomes, and comparing the clinical outcomes of... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Tenofovir-based Rescue Therapy for Patients with Drug-resistant Chronic Hepatitis B
-
Choi K, Lee HM, Jun BG, Lee SH, Kim HS, Kim SG, Kim YS, Kim BS, Jeong SW, Jang JY, Kim YD, Cheon GJ
- KMID: 2373178
- Korean J Gastroenterol.
- 2015 Jan;65(1):35-42.
- doi: 10.4166/kjg.2015.65.1.35
BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) plays a pivotal role in the management of drug-resistant chronic hepatitis B. However, it remains unclear whether TDF-nucleoside analogue combination therapy provides better outcomes than... -
- CITED
-
- Close
- SHARE
-
- Close
